Moreover, in comparison to those with inactive SLE, patients with active SLE have significantly increased IL-38 levels [30], and the concentration of IL-38 is closely correlated with the risk of renal and central nervous system complications [30]. The gene discussed is IL1F10; the disease is systemic lupus erythematosus.